PHYOF vs REGN: Which Stock is Better?

Side-by-side comparison of IXICO plc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

PHYOF

IXICO plc

$0.07

REGN

Regeneron Pharmaceuticals Inc

$746.00

Key Metrics Comparison

MetricPHYOFREGNWinner
Market Cap$71.35M$79.71BREGN
P/E RatioN/A18.18REGN
EPS (TTM)$N/A$41.47REGN
Revenue Growth0.0%0.0%PHYOF
Gross Margin48.7%44.6%PHYOF

Analyze PHYOF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PHYOF or REGN a better investment?

Comparing PHYOF and REGN: IXICO plc has a market cap of $71.35M while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PHYOF and REGN?

PHYOF (IXICO plc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PHYOF or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PHYOF or REGN?

PHYOF has higher revenue growth at 0.0% vs 0.0% for REGN.

Which company is more profitable: PHYOF or REGN?

IXICO plc (PHYOF) has higher gross margins at 48.7% compared to 44.6% for REGN.

Which is the larger company: PHYOF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $71.35M for PHYOF.

Should I buy PHYOF or REGN in 2026?

Both PHYOF and REGN have investment merit. PHYOF trades at $0.07 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PHYOF and REGN stock?

Key differences: Market Cap ($71.35M vs $79.71B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (48.7% vs 44.6%).

Popular Stock Comparisons